First, it's completely understandable to feel anxious about all of this — you've already been through so much, including a scary ER visit. Those feelings are valid, and it makes sense to want to understand your options fully.
Regarding recurrence risk with TNBC, around 40% of people with stage 1-3 TNBC may experience Show Full Answer
First, it's completely understandable to feel anxious about all of this — you've already been through so much, including a scary ER visit. Those feelings are valid, and it makes sense to want to understand your options fully.
Regarding recurrence risk with TNBC, around 40% of people with stage 1-3 TNBC may experience recurrence, often within the first three to five years. However, it's important to remember that the majority of people treated for TNBC do not relapse.
Not being able to continue immunotherapy doesn't mean you're without protection. Capecitabine is a recognized treatment path, and your doctor is clearly working to build a plan that your body can actually tolerate — which matters enormously. Regarding Zometa (zoledronic acid), it's a bone-strengthening medication often used after breast cancer treatment to help reduce the risk of recurrence in bone and protect bone density. Fear of a new medication is completely normal, especially after what you experienced with immunotherapy.
It's really worth having an open, honest conversation with your oncologist about:
- Your specific fears about Zometa based on what you've heard
- What side effects are most common vs. serious
- How your previous reaction to immunotherapy might affect how they monitor you
- Whether there are ways to manage potential side effects proactively
Many MyBCTeam members have found that talking through fears with their care team — and hearing from others who've been on similar medications — helps them feel more prepared and less alone in these decisions.
Your doctor knows your full history and is best placed to weigh the benefits against the risks for *you* specifically. Don't hesitate to ask all your questions — no question is too small when it comes to your health.
October 25